Research / AVGO / Fundamental state Inspectable configuration
State dimensions Filing 0001730168-20-000226 General Corporate
Debt relative to revenue 20th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.debt_to_revenue
171.89% · OPTIONAL · VALID
Capex intensity 44th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.94% · OPTIONAL · VALID
Operating cash generation 78th Own-history percentile · N=9
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
50.49% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
5.71% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 10th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
4.20% · OPTIONAL · VALID
Gross margin 90th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.gross_margin
56.58% · CORE · VALID
Operating margin 50th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.operating_margin
16.80% · CORE · VALID
R&D intensity 50th Own-history percentile · N=10
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
20.80% · OPTIONAL · VALID
SBC intensity 50th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
8.27% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 23 states Self-history eligible
Feb 3, 2019 0/8 normalized Level 3 May 5, 2019 0/9 normalized Level 3 Aug 4, 2019 0/9 normalized Level 3 Nov 3, 2019 0/9 normalized Level 3 Feb 2, 2020 0/9 normalized Level 3 May 3, 2020 6/9 normalized Level 3 Aug 2, 2020 8/9 normalized Level 3 Nov 1, 2020 8/9 normalized Level 3 Jan 31, 2021 8/9 normalized Level 3 May 2, 2021 9/9 normalized Level 3 Aug 1, 2021 9/9 normalized Level 3 Oct 31, 2021 9/9 normalized Level 3 Jan 30, 2022 9/9 normalized Level 3 May 1, 2022 9/9 normalized Level 3 Jul 31, 2022 9/9 normalized Level 3 Oct 30, 2022 8/8 normalized Level 3 Jan 29, 2023 8/8 normalized Level 3 Apr 30, 2023 8/8 normalized Level 3 Jul 30, 2023 8/8 normalized Level 3 Aug 2, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 755.13%
Current 171.89%
Delta -583.23% Capex Intensity Increased
Previous 1.80%
Current 1.94%
Delta 0.13% Cash Generation Decreased
Previous 54.60%
Current 50.49%
Delta -4.11% Growth Increased
Previous 5.55%
Current 5.71%
Delta 0.16% Inventory Pressure Decreased
Previous 18.57%
Current 4.20%
Delta -14.37% Margin Decreased
Previous 56.97%
Current 56.58%
Delta -0.39% Profitability Decreased
Previous 17.32%
Current 16.80%
Delta -0.51% R And D Intensity Decreased
Previous 21.10%
Current 20.80%
Delta -0.30% Sbc Intensity Increased
Previous 7.99%
Current 8.27%
Delta 0.28% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.